Blue Trust’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Blue Trust's IHE Position: Q3 2026 in Review
Blue Trust opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 7 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #2230 among its holdings. This is a return to the name: Blue Trust previously reported a position in IHE as recently as Q4 2024.
Blue Trust first reported a position in IHE in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.51K in Q4 2024. 216 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Blue Trust held 7 shares of iShares US Pharmaceuticals ETF worth $713 as of Q3 2026.
- iShares US Pharmaceuticals ETF was a new Blue Trust position in Q3 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2230 holding.
- Blue Trust first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 2 quarters since.
- Blue Trust's iShares US Pharmaceuticals ETF position peaked at $1.51K in Q4 2024.
- 216 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.